Portugal · Series A startup

Who invested in Mondego Bio

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2025, from 1 source

Latest round
Series ASept 2025
Led by
Biovance Capital
Investors
3 (1 led)
See who backed them

The rounds

  1. Sept 2025
    Series AAmount undisclosed

    Reported by Biovance Capital

Founders and team

From Mondego Bio's own website: 7 on the team.

  • Nikolay SavchukChief Executive Officer
  • Alexei PushechnikovHead of Medicinal Chemistry
  • Kate DokukinaHead of Clinical Operations
  • Ruben KarapetyanHead of Non-Clinical Development
  • Iain DukesChairman
  • João IncioBoard Director
  • Rita SantosExternal Outreach Director

Everyone who backed them

Biovance CapitalVC firm1round, led 1
OrbiMedPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Mondego Bio

Who invested in Mondego Bio?

Mondego Bio's investors include Biovance Capital, OrbiMed and Torrey Pines Investment. Biovance Capital led its latest round.

How much has Mondego Bio raised?

Mondego Bio has raised 1 round since 2025, none with a disclosed amount.

When did Mondego Bio last raise?

Mondego Bio's most recent round was a Series A in Sept 2025, led by Biovance Capital.

Who backed Mondego Bio first?

Mondego Bio's first round on record, in Sept 2025, was backed by Biovance Capital, OrbiMed and Torrey Pines Investment.

What stage is Mondego Bio at?

Mondego Bio's latest named round is a Series A, in Sept 2025.

Where is Mondego Bio based?

Mondego Bio is based in Portugal.

Who led Mondego Bio's rounds?

Biovance Capital led the Series A in 2025.

Companies like Mondego Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.